Scientists can start using taxpayer dollars to do research with 13 batches of embryonic stem cells and the government says dozens more cell lines should be available soon, opening a new era for the potentially life-saving field.
New era in stem-cell research begins
President Barack Obama lifted eight years of restrictions on these master cells last spring. But $21 million-and-counting in new projects were on hold until the National Institutes of Health determined which of hundreds of existing stem cell lines were ethically appropriate to use.
“This is the first down payment,” Francis Collins, NIH’s director, said as he opened a master registry. “People are champing at the bit for the opportunity to get started.”
Thirteen stemcell lines—created by Children's Hospital Boston and Rockefeller University in New York—are first on that list. Another 96 embryonic stem cell lines are undergoing NIH review, and 20 or more could get a decision by Dec. 4, Collins said. And researchers have notified the NIH that they may apply for approval of another 250 stem cell lines.
What do you think? Post a comment on this article and share your opinion with other readers. Submit your comments to Modern Healthcare Online at [email protected]. Please be sure to include your hometown and state, along with your organization and title.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.